| Role |
Name |
Disclosure |
Details |
| Author | W Douglas Tynan, PhD, Chief Psychologist, Nemours Health and Prevention Division Programs; Director, Primary Care Mental Health Program, A I duPont Hospital for Children; Consulting Psychologist, Nemours Clinical Management | Nothing to disclose | Details | | Medical Editor | Carol Diane Berkowitz, MD, Executive Vice Chair, Department of Pediatrics, Professor, Harbor-University of California at Los Angeles Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | CME Editor | Carrie Sylvester, MD, MPH, Director of Education in Child and Adolescent Psychiatry, Professor, Departments of Psychiatry and Pediatrics, Northwestern University Medical School | Nothing to disclose | Details | | Chief Editor | Caroly Pataki, MD, Professor of Clinical Psychiatry, Department of Psychiatry and Biobehavioral Sciences, Division Chair of Child and Adolescent Psychiatry, Director of Training, Child and Adolescent Psychiatry Residency Program, University of Southern California Keck School of Medicine | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Carrie Sylvester, CME Editor |
The contributor discloses no conflict of interest. |
|